Establishment of growth stimulating gene 2 protein time-resolved fluorescence immunoassay and its application in sepsis

J Immunol Methods. 2023 Sep:520:113534. doi: 10.1016/j.jim.2023.113534. Epub 2023 Aug 7.

Abstract

Aim: This study aimed to establish a highly sensitive time-resolved fluorescence immunoassay of growth stimulating express gene 2 protein (ST2-TRFIA) and evaluate its application value for sepsis.

Methods: Two types of ST2 monoclonal specific antibodies against different epitopes of antigen molecule were used as coating and Eu3+-labeled antibodies. The double-antibody sandwich method was used in establishing ST2-TRFIA, and the methodology was evaluated. The established ST2-TRFIA was used in detecting ST2 concentration in the plasma samples of healthy controls and sepsis.

Results: The linear range of ST2-TRFIA was 1.446-500 ng/mL. Plasma ST2 concentrations detected through ST2-TRFIA were consistent with the results of fluorescence quantitative immunochromatography (ρ = 0.946). The plasma ST2 concentrations of patients with sepsis were significantly higher than those of healthy controls (P < 0.01).

Conclusion: This study successfully established a highly sensitive ST2-TRFIA, which was highly comparable to commercially available fluorescent quantitative immunochromatographic kits and can facilitate the timely diagnosis of sepsis.

Keywords: Growth stimulating express gene 2 protein; Sepsis; Septic shock; Time-resolved fluorescence immunoassay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Fluoroimmunoassay / methods
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein*
  • Sensitivity and Specificity
  • Sepsis* / diagnosis

Substances

  • Interleukin-1 Receptor-Like 1 Protein
  • Antibodies, Monoclonal